BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 7498233)

  • 1. High Yield Production and Radiochemical Isolation of Isotopically Pure Arsenic-72 and Novel Radioarsenic Labeling Strategies for the Development of Theranostic Radiopharmaceuticals.
    Ellison PA; Barnhart TE; Chen F; Hong H; Zhang Y; Theuer CP; Cai W; Nickles RJ; DeJesus OT
    Bioconjug Chem; 2016 Jan; 27(1):179-88. PubMed ID: 26646989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies as drug carriers. II. For proteins.
    Rehlaender BN; Cho MJ
    Pharm Res; 2001 Jun; 18(6):753-60. PubMed ID: 11474778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iodine-123 labelled radiopharmaceuticals and single-photon emission tomography: a natural liaison.
    Bourguignon MH; Pauwels EK; Loc'h C; Mazière B
    Eur J Nucl Med; 1997 Mar; 24(3):331-44. PubMed ID: 9143474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiopharmaceuticals for scintigraphic imaging of infection and inflammation.
    Boerman OC; Dams ET; Oyen WJ; Corstens FH; Storm G
    Inflamm Res; 2001 Feb; 50(2):55-64. PubMed ID: 11289655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in cell labelling.
    Peters AM
    Nucl Med Commun; 1987 May; 8(5):313-6. PubMed ID: 3317158
    [No Abstract]   [Full Text] [Related]  

  • 6. Experience with the iodine-123 and technetium-99m labelled anti-granulocyte antibody MAb47: a comparison of labelling methods.
    Bläuenstein P; Locher JT; Seybold K; Koprivova H; Janoki GA; Mäcke HR; Hasler P; Ammann A; Novak-Hofer I; Smith A
    Eur J Nucl Med; 1995 Jul; 22(7):690-8. PubMed ID: 7498233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience with 99mTc-hexamethylpropylene-amineoxime for labelling leucocytes and imaging inflammation.
    Peters AM; Danpure HJ; Osman S; Hawker RJ; Henderson BL; Hodgson HJ; Kelly JD; Neirinckx RD; Lavender JP
    Lancet; 1986 Oct; 2(8513):946-9. PubMed ID: 2877132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo labelling of granulocytes with 99mTc anti-NCA monoclonal antibodies for imaging inflammation.
    Joseph K; Höffken H; Bosslet K; Schorlemmer HU
    Eur J Nucl Med; 1988; 14(7-8):367-73. PubMed ID: 3181186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging of inflammation with granulocytes labelled in vivo.
    Joseph K; Höffken H; Bosslet K; Schorlemmer HU
    Nucl Med Commun; 1988 Oct; 9(10):763-9. PubMed ID: 3211435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of accumulation of 99mTc-sulesomab in inflammation.
    Skehan SJ; White JF; Evans JW; Parry-Jones DR; Solanki CK; Ballinger JR; Chilvers ER; Peters AM
    J Nucl Med; 2003 Jan; 44(1):11-8. PubMed ID: 12515870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of 123I monoclonal granulocyte antibody and 99Tcm-HMPAO-labelled leucocytes in the detection of inflammation.
    Vorne M; Karhunen K; Lantto T; Mokka R; Mäkelä P; Nikoskelainen J; Rajamäki A
    Nucl Med Commun; 1988 Sep; 9(9):623-9. PubMed ID: 3186083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioimmunoconjugates in the detection of infection and inflammation.
    Corstens FH; Oyen WJ; Becker WS
    Semin Nucl Med; 1993 Apr; 23(2):148-64. PubMed ID: 8511601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human IgG3 is decreased and IgG1, IgG2 and IgG4 are unchanged in molecular size by mild reduction and reoxidation without any major change in effector functions.
    Michaelsen TE; Naess LM; Aase A
    Mol Immunol; 1993 Jan; 30(1):35-45. PubMed ID: 8417373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of soft-tissue infections and osteomyelitis using a technetium-99m-labeled anti-granulocyte monoclonal antibody fragment.
    Becker W; Bair J; Behr T; Repp R; Streckenbach H; Beck H; Gramatzki M; Winship MJ; Goldenberg DM; Wolf F
    J Nucl Med; 1994 Sep; 35(9):1436-43. PubMed ID: 8071688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies identify a CEA crossreacting antigen of 95 kD (NCA-95) distinct in antigenicity and tissue distribution from the previously described NCA of 55 kD.
    Buchegger F; Schreyer M; Carrel S; Mach JP
    Int J Cancer; 1984 May; 33(5):643-9. PubMed ID: 6724739
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.